Trial Profile

Efficacy and Safety of Olmertasan in elderly patients with mild to moderate hypertension

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 02 Jun 2011

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Olmesartan medoxomil (Primary) ; Ramipril
Indications Essential hypertension
Focus Therapeutic Use
Acronyms ESPORT

Most Recent Events

08 Sep 2010 An open-label follow-on study will continue on from the 12-week randomisation portion of this trial, as reported in Journal of hypertension.
08 Sep 2010 Full results were presentd in an article in the Journal of Hypertension.
21 Jun 2010 Results presented at the 20th European Meeting on Hypertension.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com